Antigens, Differentiation, Myelomonocytic
"Antigens, Differentiation, Myelomonocytic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukemias and lymphomas.
Descriptor ID |
D015214
|
MeSH Number(s) |
D23.050.301.264.900 D23.101.100.900
|
Concept/Terms |
Antigens, Differentiation, Myelomonocytic- Antigens, Differentiation, Myelomonocytic
- Myelomonocytic Differentiation Antigens
- Antigens, Myelomonocytic, Differentiation
- Differentiation Antigens, Myelomonocytic
- Antigens, Myelomonocytic Differentiation
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Differentiation, Myelomonocytic".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Differentiation, Myelomonocytic".
This graph shows the total number of publications written about "Antigens, Differentiation, Myelomonocytic" by people in this website by year, and whether "Antigens, Differentiation, Myelomonocytic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2000 | 1 | 1 | 2 |
2002 | 1 | 1 | 2 |
2003 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2007 | 0 | 2 | 2 |
2012 | 0 | 1 | 1 |
2013 | 0 | 2 | 2 |
2014 | 0 | 2 | 2 |
2015 | 0 | 1 | 1 |
2016 | 0 | 2 | 2 |
2017 | 0 | 1 | 1 |
2018 | 3 | 1 | 4 |
2020 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, Differentiation, Myelomonocytic" by people in Profiles.
-
From the archives of MD Anderson Cancer Center. Mesothelial/monocytic incidental cardiac excrescence with a review of the literature. Ann Diagn Pathol. 2024 Aug; 71:152296.
-
CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease. Front Immunol. 2021; 12:745893.
-
Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis. Front Immunol. 2021; 12:744184.
-
Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages. Front Immunol. 2020; 11:671.
-
Plasmablastic Lymphomas: Characterization of Tumor Microenvironment Using CD163 and PD-1 Immunohistochemistry. Ann Clin Lab Sci. 2020 Mar; 50(2):213-218.
-
Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. J Immunother Cancer. 2020 02; 8(1).
-
Xanthomatous Thymoma: A Clinicopathologic and Immunohistochemical Study of 10 Cases. Am J Clin Pathol. 2019 05 03; 151(6):593-597.
-
A role for bone marrow-derived cells in diabetic nephropathy. FASEB J. 2019 03; 33(3):4067-4076.
-
Fine-needle aspiration of alveolar soft part sarcoma: Histologic correlation and aberrant CD68 expression. Diagn Cytopathol. 2019 Feb; 47(2):114-120.
-
Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. Surgery. 2018 11; 164(5):960-964.